董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Mark C. Throdahl | 男 | President and Chief Executive Officer,Director | 68 | 119.02万美元 | 未持股 | 2020-03-05 |
| Terry D. Schlotterback | 男 | Director and Chairman of the Board of Director | 64 | 8.38万美元 | 未持股 | 2020-03-05 |
| Bernie B. Berry, III | 男 | Director | 67 | 7.78万美元 | 未持股 | 2020-03-05 |
| Bryan W. Hughes | 男 | Director | 42 | 8.08万美元 | 未持股 | 2020-03-05 |
| Marie C. Infante | 女 | Director | 70 | 8.08万美元 | 未持股 | 2020-03-05 |
| David R. Pelizzon | 男 | Director | 64 | 7.78万美元 | 未持股 | 2020-03-05 |
| Kevin L. Unger | 男 | Director | 48 | 7.78万美元 | 未持股 | 2020-03-05 |
| Stephen F. Burns | 男 | Director | 76 | 7.78万美元 | 未持股 | 2020-03-05 |
| Harald Ruf | 男 | Director | 66 | 7.78万美元 | 未持股 | 2020-03-05 |
| Fred L. Hite | 男 | Chief Financial Officer and Director | 52 | 100.16万美元 | 未持股 | 2020-03-05 |
| Samuel D. Riccitelli | 男 | Director | 60 | 7.78万美元 | 未持股 | 2020-03-05 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Mark C. Throdahl | 男 | President and Chief Executive Officer,Director | 68 | 119.02万美元 | 未持股 | 2020-03-05 |
| David R. Bailey | 男 | Executive Vice President | 40 | 83.55万美元 | 未持股 | 2020-03-05 |
| Gregory A. Odle | 男 | Executive Vice President | 50 | 83.61万美元 | 未持股 | 2020-03-05 |
| Daniel J. Gerritzen | 男 | Vice President, General Counsel and Secretary | 50 | 80.02万美元 | 未持股 | 2020-03-05 |
| Fred L. Hite | 男 | Chief Financial Officer and Director | 52 | 100.16万美元 | 未持股 | 2020-03-05 |
董事简历
中英对照 | 中文 | 英文- Mark C. Throdahl
-
Mark C. Throdahl，自2011年1月起担任公司总裁兼首席执行官，自2009年起担任公司董事。加入本公司前，2008年至2009年，Mr. Throdahl曾担任Zimmer Holdings, Inc（全球医用植入材料领导者）集团总裁。2001年至2007年，Mr. Throdahl曾担任英国伦敦Consort Medical plc首席执行官兼董事。在Becton Dickinson & Co。任职的13年间，他曾担任Drug Delivery sector高级副总裁以及东京Nippon Becton Dickinson总裁。Mr. Throdahl 在Mallinckrodt, Inc开始他的职业生涯。 Mr. Throdahl毕业于Princeton University，同时获得了Harvard Business School工商管理硕士学位。
Mark C. Throdahl has served as our President and Chief Executive Officer since January 2011 and as a director since 2009. Prior to joining our company, Mr. Throdahl served from 2008 to 2009 as a Group President of Zimmer Holdings, Inc., a worldwide leader in orthopedic implants. Mr. Throdahl previously served from 2001 to 2007 as the Chief Executive Officer and Director of Consort Medical plc in London, United Kingdom. During a 13 year career at Becton Dickinson & Co., he served as Senior Vice President of the Drug Delivery sector and President of Nippon Becton Dickinson in Tokyo. Mr. Throdahl began his career at Mallinckrodt, Inc. Mr. Throdahl is a graduate of Princeton University and earned an MBA from Harvard Business School. - Mark C. Throdahl，自2011年1月起担任公司总裁兼首席执行官，自2009年起担任公司董事。加入本公司前，2008年至2009年，Mr. Throdahl曾担任Zimmer Holdings, Inc（全球医用植入材料领导者）集团总裁。2001年至2007年，Mr. Throdahl曾担任英国伦敦Consort Medical plc首席执行官兼董事。在Becton Dickinson & Co。任职的13年间，他曾担任Drug Delivery sector高级副总裁以及东京Nippon Becton Dickinson总裁。Mr. Throdahl 在Mallinckrodt, Inc开始他的职业生涯。 Mr. Throdahl毕业于Princeton University，同时获得了Harvard Business School工商管理硕士学位。
- Mark C. Throdahl has served as our President and Chief Executive Officer since January 2011 and as a director since 2009. Prior to joining our company, Mr. Throdahl served from 2008 to 2009 as a Group President of Zimmer Holdings, Inc., a worldwide leader in orthopedic implants. Mr. Throdahl previously served from 2001 to 2007 as the Chief Executive Officer and Director of Consort Medical plc in London, United Kingdom. During a 13 year career at Becton Dickinson & Co., he served as Senior Vice President of the Drug Delivery sector and President of Nippon Becton Dickinson in Tokyo. Mr. Throdahl began his career at Mallinckrodt, Inc. Mr. Throdahl is a graduate of Princeton University and earned an MBA from Harvard Business School.
- Terry D. Schlotterback
-
Terry D. Schlotterback自2009年起担任董事，并自2013年9月起担任董事长。Schlotterback先生2009年2月至2010年2月受雇于我们。在加入我们的董事会之前，1982年至1992年Schlotterback先生任职于Zimmer；1996年至2006年，他在销售，营销和研发方面担任过各种领导职位，包括作为创伤和脊柱部门的总裁。 在加入Zimmer之前，Schlotterback先生于1992年至1995年在Mitek Surgical Products担任高级管理职务。Schlotterback先生是 Warsaw, Indiana chapter of VisionTech Angels（一家投资集团）和TDS Consulting, LLC（向医疗初创公司提供 咨询服务）的创始人之一。 Schlotterback先生在 Purdue University获得机械工程技术学士学位。
Terry D. Schlotterback has served as a director since 2009 and as Chairman of the Board of Directors since September 2013. Mr. Schlotterback was also employed by us from February 2009 to February 2010. Prior to joining our Board of Directors, Mr. Schlotterback worked for Zimmer from 1982 to 1992 and from 1996 to 2006 where he served in various leadership positions in sales, marketing and research and development, including as President of the Trauma and Spinal divisions. Prior to joining Zimmer, Mr. Schlotterback served in senior management roles for Mitek Surgical Products from 1992 to 1995. Mr. Schlotterback is a founder of the Warsaw, Indiana chapter of VisionTech Angels, an investment group, and TDS Consulting, LLC, which provides consulting services to medical startup companies. Mr. Schlotterback earned a Bachelor of Science in Mechanical Engineering Technology from Purdue University. - Terry D. Schlotterback自2009年起担任董事，并自2013年9月起担任董事长。Schlotterback先生2009年2月至2010年2月受雇于我们。在加入我们的董事会之前，1982年至1992年Schlotterback先生任职于Zimmer；1996年至2006年，他在销售，营销和研发方面担任过各种领导职位，包括作为创伤和脊柱部门的总裁。 在加入Zimmer之前，Schlotterback先生于1992年至1995年在Mitek Surgical Products担任高级管理职务。Schlotterback先生是 Warsaw, Indiana chapter of VisionTech Angels（一家投资集团）和TDS Consulting, LLC（向医疗初创公司提供 咨询服务）的创始人之一。 Schlotterback先生在 Purdue University获得机械工程技术学士学位。
- Terry D. Schlotterback has served as a director since 2009 and as Chairman of the Board of Directors since September 2013. Mr. Schlotterback was also employed by us from February 2009 to February 2010. Prior to joining our Board of Directors, Mr. Schlotterback worked for Zimmer from 1982 to 1992 and from 1996 to 2006 where he served in various leadership positions in sales, marketing and research and development, including as President of the Trauma and Spinal divisions. Prior to joining Zimmer, Mr. Schlotterback served in senior management roles for Mitek Surgical Products from 1992 to 1995. Mr. Schlotterback is a founder of the Warsaw, Indiana chapter of VisionTech Angels, an investment group, and TDS Consulting, LLC, which provides consulting services to medical startup companies. Mr. Schlotterback earned a Bachelor of Science in Mechanical Engineering Technology from Purdue University.
- Bernie B. Berry, III
-
Bernie B. Berry, III，2009年以来，他曾担任董事。他是Carr Metal Products, Inc.（精密钣金和塑料装饰公司）的前任总裁兼所有者。他于1975年加入Carr公司，并于1985年被任命为总裁。Carr公司于2006年被Precimed Group（整形行业的供应商）收购。他毕业于Purdue University。
Bernie B. Berry, III has served as a director since 2009. Mr. Berry is the former President and owner of Carr Metal Products, Inc., a precision sheet metal and plastic fabrications firm. Mr. Berry joined Carr in 1975 and was appointed its President in 1985. In 2006 Carr was acquired by Precimed Group, a supplier to the orthopedic industry. Mr. Berry is a graduate of Purdue University. - Bernie B. Berry, III，2009年以来，他曾担任董事。他是Carr Metal Products, Inc.（精密钣金和塑料装饰公司）的前任总裁兼所有者。他于1975年加入Carr公司，并于1985年被任命为总裁。Carr公司于2006年被Precimed Group（整形行业的供应商）收购。他毕业于Purdue University。
- Bernie B. Berry, III has served as a director since 2009. Mr. Berry is the former President and owner of Carr Metal Products, Inc., a precision sheet metal and plastic fabrications firm. Mr. Berry joined Carr in 1975 and was appointed its President in 1985. In 2006 Carr was acquired by Precimed Group, a supplier to the orthopedic industry. Mr. Berry is a graduate of Purdue University.
- Bryan W. Hughes
-
Bryan W. Hughes，自2012年起担任董事。他自2008年起担任P&M Corporate Finance, LLC（投资银行，为北美和欧洲地区企业提供并购服务）的董事兼医疗技术投资银行业务全球主管。他获得了the Stephen M. Ross School of Business at the University of Michigan的金融学和会计学工商管理学士学位。他是一名持牌证券代表，持系列7和63号牌。
Bryan W. Hughes has served as a director since 2012. Mr. Hughes is the Managing Director and Group Head of Medical Technology Investment Banking at P&M Corporate Finance, LLC, an investment bank providing merger and acquisition services to companies throughout North America and Europe, a position he has held since 2008. Mr. Hughes earned a B.B.A. with an emphasis in Finance and Accounting from the Stephen M. Ross School of Business at the University of Michigan. Mr. Hughes is a licensed securities representative, holding Series 7 and 63 registrations. - Bryan W. Hughes，自2012年起担任董事。他自2008年起担任P&M Corporate Finance, LLC（投资银行，为北美和欧洲地区企业提供并购服务）的董事兼医疗技术投资银行业务全球主管。他获得了the Stephen M. Ross School of Business at the University of Michigan的金融学和会计学工商管理学士学位。他是一名持牌证券代表，持系列7和63号牌。
- Bryan W. Hughes has served as a director since 2012. Mr. Hughes is the Managing Director and Group Head of Medical Technology Investment Banking at P&M Corporate Finance, LLC, an investment bank providing merger and acquisition services to companies throughout North America and Europe, a position he has held since 2008. Mr. Hughes earned a B.B.A. with an emphasis in Finance and Accounting from the Stephen M. Ross School of Business at the University of Michigan. Mr. Hughes is a licensed securities representative, holding Series 7 and 63 registrations.
- Marie C. Infante
-
Marie C. Infante，她一直担任董事（2014年以来）。她目前担任Avalon Healthcare的临时合规主管（2015年以来）、Triple Tree Capital Partners的高级顾问（2013年以来）、BDO Consulting Center for Healthcare Excellence & Innovation的高级顾问（2013年以来）。2006年至2013年，她曾担任Healthcare Law for Golden Living的高级副总裁、首席合规官和总法律顾问。她也曾担任临床骨科护理专家15年。她毕业于the University of Maryland，在那里她获得护理学学士和理学硕士学位。她获得了Loyola University的工商管理硕士学位，以及the Catholic University of America的法学博士学位。
Marie C. Infante has served as a director since 2014. Ms. Infante was nominated pursuant to the Stockholders' Agreement with Squadron Capital LLC. Her prior experience as a director includes educational, non-profit, and professional organizations. Ms. Infante has more than 25 years of experience as a healthcare lawyer and a certified compliance professional. Since 2013 she has been an active consultant and senior advisor in the healthcare industry. Recent affiliations have included Avalon Healthcare Services, Zimmet Healthcare Services Group, Triple Tree Capital Partners and BDO Center for Healthcare Excellence and Innovation. From 2006 to 2013 she served as the Senior Vice President, Chief Compliance Officer and General Counsel for Healthcare Law for a $3 billion leader in post-acute heathcare services whose 42000 employees cared for over 60000 patients annually. Her industry expertise also stems from 15 years as a clinical specialist in orthopedic nursing. Ms. Infante is a graduate of the University of Maryland, where she earned a Bachelor of Science in Nursing and a Master of Science. She also holds an MBA from Loyola University and a JD from the Catholic University of America. - Marie C. Infante，她一直担任董事（2014年以来）。她目前担任Avalon Healthcare的临时合规主管（2015年以来）、Triple Tree Capital Partners的高级顾问（2013年以来）、BDO Consulting Center for Healthcare Excellence & Innovation的高级顾问（2013年以来）。2006年至2013年，她曾担任Healthcare Law for Golden Living的高级副总裁、首席合规官和总法律顾问。她也曾担任临床骨科护理专家15年。她毕业于the University of Maryland，在那里她获得护理学学士和理学硕士学位。她获得了Loyola University的工商管理硕士学位，以及the Catholic University of America的法学博士学位。
- Marie C. Infante has served as a director since 2014. Ms. Infante was nominated pursuant to the Stockholders' Agreement with Squadron Capital LLC. Her prior experience as a director includes educational, non-profit, and professional organizations. Ms. Infante has more than 25 years of experience as a healthcare lawyer and a certified compliance professional. Since 2013 she has been an active consultant and senior advisor in the healthcare industry. Recent affiliations have included Avalon Healthcare Services, Zimmet Healthcare Services Group, Triple Tree Capital Partners and BDO Center for Healthcare Excellence and Innovation. From 2006 to 2013 she served as the Senior Vice President, Chief Compliance Officer and General Counsel for Healthcare Law for a $3 billion leader in post-acute heathcare services whose 42000 employees cared for over 60000 patients annually. Her industry expertise also stems from 15 years as a clinical specialist in orthopedic nursing. Ms. Infante is a graduate of the University of Maryland, where she earned a Bachelor of Science in Nursing and a Master of Science. She also holds an MBA from Loyola University and a JD from the Catholic University of America.
- David R. Pelizzon
-
David R. Pelizzon自2011年起担任董事。Pelizzon先生是Squadron的总裁兼首席执行官，自2008年以来一直担任该职位。在加入Squadron之前，2005年至2008年，Pelizzon先生是Precision Edge Surgical Products的董事总经理 。Pelizzon先生是退役的美国陆军军官，在空降和特种作战部队服役将近30年。 Pelizzon先生毕业于美国军事学院，并获得Harvard University 和U.S. Naval War College的高等学位。
David R. Pelizzon has served as a director since 2011. Mr. Pelizzon was nominated pursuant to the Stockholders' Agreement with Squadron Capital LLC. Mr. Pelizzon is the President of Squadron and a member of its Managing Committee, positions he has held since 2008. Prior to joining Squadron, Mr. Pelizzon was the Managing Director of Precision Edge Surgical Products Company from 2005 to 2008. Mr. Pelizzon is a retired U.S. Army officer who served nearly 30 years on active duty in airborne and special operations units. Mr. Pelizzon is a graduate of the U.S. Military Academy and earned advanced degrees from Harvard University and the U.S. Naval War College. - David R. Pelizzon自2011年起担任董事。Pelizzon先生是Squadron的总裁兼首席执行官，自2008年以来一直担任该职位。在加入Squadron之前，2005年至2008年，Pelizzon先生是Precision Edge Surgical Products的董事总经理 。Pelizzon先生是退役的美国陆军军官，在空降和特种作战部队服役将近30年。 Pelizzon先生毕业于美国军事学院，并获得Harvard University 和U.S. Naval War College的高等学位。
- David R. Pelizzon has served as a director since 2011. Mr. Pelizzon was nominated pursuant to the Stockholders' Agreement with Squadron Capital LLC. Mr. Pelizzon is the President of Squadron and a member of its Managing Committee, positions he has held since 2008. Prior to joining Squadron, Mr. Pelizzon was the Managing Director of Precision Edge Surgical Products Company from 2005 to 2008. Mr. Pelizzon is a retired U.S. Army officer who served nearly 30 years on active duty in airborne and special operations units. Mr. Pelizzon is a graduate of the U.S. Military Academy and earned advanced degrees from Harvard University and the U.S. Naval War College.
- Kevin L. Unger
-
Kevin L. Unger，2011年以来，他担任董事。2015年以来，他一直担任Columbia Nutritional, LLC（营养补充制造公司）的首席执行官。从2011年到2015年，他曾担任Intrinsic Healthcare Inc.的首席执行官。创办Intrinsic之前从2009年到2011年，他担任Orthofix International N.V。（脊柱植入物和生物制剂业务）的全球总裁。从1994年到2009年，他担任Stryker Corporation的各种职位。最终他成为MedSurg部门的副总裁和总经理。
Kevin L. Unger has served as a director since 2011. Mr. Unger is currently the Chief Executive Officer of Columbia Nutritional, LLC, a nutritional supplement manufacturing company, a position he has held since 2015. He served as the Chief Executive Officer of Intrinsic Healthcare Inc. from 2011 to 2015. Prior to founding Intrinsic, he served as the Global President of Orthofix International N.V., a spinal implant and biologics business, from 2009 to 2011. Mr. Unger held various roles for Stryker Corporation from 1994 to 2009 ultimately becoming a Vice President and General Manager in the MedSurg division. - Kevin L. Unger，2011年以来，他担任董事。2015年以来，他一直担任Columbia Nutritional, LLC（营养补充制造公司）的首席执行官。从2011年到2015年，他曾担任Intrinsic Healthcare Inc.的首席执行官。创办Intrinsic之前从2009年到2011年，他担任Orthofix International N.V。（脊柱植入物和生物制剂业务）的全球总裁。从1994年到2009年，他担任Stryker Corporation的各种职位。最终他成为MedSurg部门的副总裁和总经理。
- Kevin L. Unger has served as a director since 2011. Mr. Unger is currently the Chief Executive Officer of Columbia Nutritional, LLC, a nutritional supplement manufacturing company, a position he has held since 2015. He served as the Chief Executive Officer of Intrinsic Healthcare Inc. from 2011 to 2015. Prior to founding Intrinsic, he served as the Global President of Orthofix International N.V., a spinal implant and biologics business, from 2009 to 2011. Mr. Unger held various roles for Stryker Corporation from 1994 to 2009 ultimately becoming a Vice President and General Manager in the MedSurg division.
- Stephen F. Burns
-
StephenF.Burns自2017年4月起担任董事。Burns从1987年到2009年退休担任Wheaton Van Lines，Inc.总裁和首席执行官。在运营Wheaton Van Lines之前，Burns先生担任了20多年的执业律师。他在印第安纳波利斯地区拥有超过40年的专业和法律经验。他自1987年起担任Wheaton Van Lines的董事会主席，自2002年起担任Bekins Van Lines，Inc.的董事会主席。Burns先生在他的整个职业生涯中一直活跃在许多专业、社会和公民组织。2006年，他被安永会计师事务所（Ernst and Young LLP）评为印第安纳州年度企业家。2008年他获得the American Moving&Storage Association的终身成就奖。Burns先生在丹尼森大学（Denison University）获得文学学士学位，并在印第安纳大学毛雷尔法学院（Indiana University Maurer School of Law）获得法学博士学位。
Stephen F. Burns has served as a director since April 2017. Mr. Burns served as President and Chief Executive Officer of Wheaton Van Lines, Inc. from 1987 until his retirement in 2009. Prior to running Wheaton Van Lines, Mr. Burns was a practicing attorney for over 20 years. He has over 40 years of professional and legal experience in the Indianapolis area. He has been the chairman of the board of directors of Wheaton Van Lines since 1987 and chairman of the board of directors of Bekins Van Lines, Inc. since 2002. Mr. Burns has been active in many professional, social and civic organizations throughout his career. In 2006 he was recognized by Ernst and Young LLP as Entrepreneur of the Year for the State of Indiana. In 2008 he received a lifetime achievement award from the American Moving & Storage Association. Mr. Burns earned a Bachelor of Arts from Denison University and a JD from the Indiana University Maurer School of Law. - StephenF.Burns自2017年4月起担任董事。Burns从1987年到2009年退休担任Wheaton Van Lines，Inc.总裁和首席执行官。在运营Wheaton Van Lines之前，Burns先生担任了20多年的执业律师。他在印第安纳波利斯地区拥有超过40年的专业和法律经验。他自1987年起担任Wheaton Van Lines的董事会主席，自2002年起担任Bekins Van Lines，Inc.的董事会主席。Burns先生在他的整个职业生涯中一直活跃在许多专业、社会和公民组织。2006年，他被安永会计师事务所（Ernst and Young LLP）评为印第安纳州年度企业家。2008年他获得the American Moving&Storage Association的终身成就奖。Burns先生在丹尼森大学（Denison University）获得文学学士学位，并在印第安纳大学毛雷尔法学院（Indiana University Maurer School of Law）获得法学博士学位。
- Stephen F. Burns has served as a director since April 2017. Mr. Burns served as President and Chief Executive Officer of Wheaton Van Lines, Inc. from 1987 until his retirement in 2009. Prior to running Wheaton Van Lines, Mr. Burns was a practicing attorney for over 20 years. He has over 40 years of professional and legal experience in the Indianapolis area. He has been the chairman of the board of directors of Wheaton Van Lines since 1987 and chairman of the board of directors of Bekins Van Lines, Inc. since 2002. Mr. Burns has been active in many professional, social and civic organizations throughout his career. In 2006 he was recognized by Ernst and Young LLP as Entrepreneur of the Year for the State of Indiana. In 2008 he received a lifetime achievement award from the American Moving & Storage Association. Mr. Burns earned a Bachelor of Arts from Denison University and a JD from the Indiana University Maurer School of Law.
- Harald Ruf
-
Harald Ruf自2017年4月起担任董事。Ruf先生是根据Squadron Capital LLC的股东协议提名的。RUF先生自2014年以来一直在Squadron工作，最初担任首席财务官，目前担任首席运营官。Ruf先生于2014年至2016年担任总部位于英国的ChromoGenex Limited的董事会成员。从2010年到2016年，Ruf先生担任Teuscher Ruf&Walpole，LLC的管理合伙人，该公司是一家提供税务，审计和咨询服务的会计师事务所。他也是RUF&Associates，LLC（他于1982年创立的咨询公司）的总裁兼首席执行官。在他的职业生涯中，他联合创立了多家跨多个行业的成功公司。Ruf先生毕业于杨百翰大学（Brigham Young University），在那里他获得了会计学理学学士学位，他是加利福尼亚州和犹他州的注册会计师。Ruf先生曾担任地方和国家公司和协会的官员和董事会成员，并因这种服务在全国范围内获得认可。
Harald Ruf has served as a director since April 2017. Mr. Ruf was nominated pursuant to the Stockholders' Agreement with Squadron Capital LLC. Mr. Ruf has worked for Squadron since 2014 first as Chief Financial Officer and currently as Chief Operating Officer. Mr. Ruf served on the board of directors of Chromogenex Limited, based in the United Kingdom, from 2014 to 2016. From 2010 to 2016 Mr. Ruf served as a Managing Partner of Teuscher Ruf & Walpole, LLC, an accounting firm providing tax, audit and consulting services. He is also the President and Chief Executive Officer of Ruf & Associates, LLC, a consulting firm that he founded in 1982. During his career, he has co-founded a number of successful companies across several industries. Mr. Ruf is a graduate of Brigham Young University, where he earned a Bachelor of Science in Accounting, and he is a licensed certified public accountant in the States of California and Utah. Mr. Ruf has served as an officer and board member for local and national companies and associations and has been recognized nationally for such service. - Harald Ruf自2017年4月起担任董事。Ruf先生是根据Squadron Capital LLC的股东协议提名的。RUF先生自2014年以来一直在Squadron工作，最初担任首席财务官，目前担任首席运营官。Ruf先生于2014年至2016年担任总部位于英国的ChromoGenex Limited的董事会成员。从2010年到2016年，Ruf先生担任Teuscher Ruf&Walpole，LLC的管理合伙人，该公司是一家提供税务，审计和咨询服务的会计师事务所。他也是RUF&Associates，LLC（他于1982年创立的咨询公司）的总裁兼首席执行官。在他的职业生涯中，他联合创立了多家跨多个行业的成功公司。Ruf先生毕业于杨百翰大学（Brigham Young University），在那里他获得了会计学理学学士学位，他是加利福尼亚州和犹他州的注册会计师。Ruf先生曾担任地方和国家公司和协会的官员和董事会成员，并因这种服务在全国范围内获得认可。
- Harald Ruf has served as a director since April 2017. Mr. Ruf was nominated pursuant to the Stockholders' Agreement with Squadron Capital LLC. Mr. Ruf has worked for Squadron since 2014 first as Chief Financial Officer and currently as Chief Operating Officer. Mr. Ruf served on the board of directors of Chromogenex Limited, based in the United Kingdom, from 2014 to 2016. From 2010 to 2016 Mr. Ruf served as a Managing Partner of Teuscher Ruf & Walpole, LLC, an accounting firm providing tax, audit and consulting services. He is also the President and Chief Executive Officer of Ruf & Associates, LLC, a consulting firm that he founded in 1982. During his career, he has co-founded a number of successful companies across several industries. Mr. Ruf is a graduate of Brigham Young University, where he earned a Bachelor of Science in Accounting, and he is a licensed certified public accountant in the States of California and Utah. Mr. Ruf has served as an officer and board member for local and national companies and associations and has been recognized nationally for such service.
- Fred L. Hite
-
Fred L. Hite，2004年3月以来，他一直担任高级副总裁兼首席财务官。他曾担任General Electric Industrial Systems公司的多种职务，包括负责一般电动马达和控制的财务经理（从2001年到2004年）、制造业财务经理（从2000年到2001年）、工程服务财务经理（从1997年到2000年）。从1995年到1997年，他曾担任General Electric Industrial Control Systems的采购财务经理和商业金融分析师。从1990年到1995年，他曾担任General Electric Appliances公司的多种财务职务。他持有印第安纳大学（Indiana University-Bloomington）的财务学士学位。
Fred L. Hite has served as our Chief Financial Officer since February 2015 and as a director since August 2015. Prior to joining our company, from 2004 through 2014 Mr. Hite served as the Chief Financial Officer and Investor Relations Officer of Symmetry Medical Inc., or Symmetry, a company previously listed on the New York Stock Exchange. Prior to joining Symmetry, Mr. Hite spent 13 years with General Electric Corporation in a variety of financial positions and areas including commercial, manufacturing, sourcing and services. Mr. Hite earned a Bachelor of Science in Finance from the Indiana University Kelley School of Business. - Fred L. Hite，2004年3月以来，他一直担任高级副总裁兼首席财务官。他曾担任General Electric Industrial Systems公司的多种职务，包括负责一般电动马达和控制的财务经理（从2001年到2004年）、制造业财务经理（从2000年到2001年）、工程服务财务经理（从1997年到2000年）。从1995年到1997年，他曾担任General Electric Industrial Control Systems的采购财务经理和商业金融分析师。从1990年到1995年，他曾担任General Electric Appliances公司的多种财务职务。他持有印第安纳大学（Indiana University-Bloomington）的财务学士学位。
- Fred L. Hite has served as our Chief Financial Officer since February 2015 and as a director since August 2015. Prior to joining our company, from 2004 through 2014 Mr. Hite served as the Chief Financial Officer and Investor Relations Officer of Symmetry Medical Inc., or Symmetry, a company previously listed on the New York Stock Exchange. Prior to joining Symmetry, Mr. Hite spent 13 years with General Electric Corporation in a variety of financial positions and areas including commercial, manufacturing, sourcing and services. Mr. Hite earned a Bachelor of Science in Finance from the Indiana University Kelley School of Business.
- Samuel D. Riccitelli
-
Samuel D. Riccitelli，2012年10月起担任公司总裁、首席执行官、董事会成员。2011年7月至2012年10月，他担任独立顾问。2001年10月至2011年6月，他担任Genoptix, Inc.执行副总裁和首席运营官，该公司是一家上市诊断服务公司，关注社区血液学家和肿瘤学家的需求。1995至2001年，他在Becton, Dickinson and Company担任多个职位，包括最近一职是副总裁和总经理，以及风险投资基金BD Ventures, L.L.C.董事会成员。1989至1994年，他在Puritan-Bennett Corporation担任多个职位，包括最近一职是总经理。他也是Exagen Diagnostics, Inc.董事会成员，自2011年10月起任董事。他获有Washington and Jefferson College生物学学士学位，以及University of Texas机械和生物医学工程专业工程硕士学位。
Samuel D. Riccitelli has served as a director since December 2017. Mr. Riccitelli currently serves as Chief Executive Officer of Pathnostics, a diagnostics company focused on improving antibiotic stewardship through better diagnosis and treatment selection for patients suffering from urinary tract infections. From November 2017 to December 2019 Mr. Riccitelli served as Chairman of the Board of Directors of Precipio, Inc. Nasdaq: PRPO. From 2012 to 2017 Mr. Riccitelli served as president and chief executive officer and a director of Signal Genetics., a publicly traded molecular diagnostic company that was ultimately sold to Miragen Therapeutics. Mr. Riccitelli was also previously the executive vice president and chief operating officer of Genoptix, Inc., a public traded diagnostic company that was sold to Novartis in 2011. - Samuel D. Riccitelli，2012年10月起担任公司总裁、首席执行官、董事会成员。2011年7月至2012年10月，他担任独立顾问。2001年10月至2011年6月，他担任Genoptix, Inc.执行副总裁和首席运营官，该公司是一家上市诊断服务公司，关注社区血液学家和肿瘤学家的需求。1995至2001年，他在Becton, Dickinson and Company担任多个职位，包括最近一职是副总裁和总经理，以及风险投资基金BD Ventures, L.L.C.董事会成员。1989至1994年，他在Puritan-Bennett Corporation担任多个职位，包括最近一职是总经理。他也是Exagen Diagnostics, Inc.董事会成员，自2011年10月起任董事。他获有Washington and Jefferson College生物学学士学位，以及University of Texas机械和生物医学工程专业工程硕士学位。
- Samuel D. Riccitelli has served as a director since December 2017. Mr. Riccitelli currently serves as Chief Executive Officer of Pathnostics, a diagnostics company focused on improving antibiotic stewardship through better diagnosis and treatment selection for patients suffering from urinary tract infections. From November 2017 to December 2019 Mr. Riccitelli served as Chairman of the Board of Directors of Precipio, Inc. Nasdaq: PRPO. From 2012 to 2017 Mr. Riccitelli served as president and chief executive officer and a director of Signal Genetics., a publicly traded molecular diagnostic company that was ultimately sold to Miragen Therapeutics. Mr. Riccitelli was also previously the executive vice president and chief operating officer of Genoptix, Inc., a public traded diagnostic company that was sold to Novartis in 2011.
高管简历
中英对照 | 中文 | 英文- Mark C. Throdahl
Mark C. Throdahl，自2011年1月起担任公司总裁兼首席执行官，自2009年起担任公司董事。加入本公司前，2008年至2009年，Mr. Throdahl曾担任Zimmer Holdings, Inc（全球医用植入材料领导者）集团总裁。2001年至2007年，Mr. Throdahl曾担任英国伦敦Consort Medical plc首席执行官兼董事。在Becton Dickinson & Co。任职的13年间，他曾担任Drug Delivery sector高级副总裁以及东京Nippon Becton Dickinson总裁。Mr. Throdahl 在Mallinckrodt, Inc开始他的职业生涯。 Mr. Throdahl毕业于Princeton University，同时获得了Harvard Business School工商管理硕士学位。
Mark C. Throdahl has served as our President and Chief Executive Officer since January 2011 and as a director since 2009. Prior to joining our company, Mr. Throdahl served from 2008 to 2009 as a Group President of Zimmer Holdings, Inc., a worldwide leader in orthopedic implants. Mr. Throdahl previously served from 2001 to 2007 as the Chief Executive Officer and Director of Consort Medical plc in London, United Kingdom. During a 13 year career at Becton Dickinson & Co., he served as Senior Vice President of the Drug Delivery sector and President of Nippon Becton Dickinson in Tokyo. Mr. Throdahl began his career at Mallinckrodt, Inc. Mr. Throdahl is a graduate of Princeton University and earned an MBA from Harvard Business School.- Mark C. Throdahl，自2011年1月起担任公司总裁兼首席执行官，自2009年起担任公司董事。加入本公司前，2008年至2009年，Mr. Throdahl曾担任Zimmer Holdings, Inc（全球医用植入材料领导者）集团总裁。2001年至2007年，Mr. Throdahl曾担任英国伦敦Consort Medical plc首席执行官兼董事。在Becton Dickinson & Co。任职的13年间，他曾担任Drug Delivery sector高级副总裁以及东京Nippon Becton Dickinson总裁。Mr. Throdahl 在Mallinckrodt, Inc开始他的职业生涯。 Mr. Throdahl毕业于Princeton University，同时获得了Harvard Business School工商管理硕士学位。
- Mark C. Throdahl has served as our President and Chief Executive Officer since January 2011 and as a director since 2009. Prior to joining our company, Mr. Throdahl served from 2008 to 2009 as a Group President of Zimmer Holdings, Inc., a worldwide leader in orthopedic implants. Mr. Throdahl previously served from 2001 to 2007 as the Chief Executive Officer and Director of Consort Medical plc in London, United Kingdom. During a 13 year career at Becton Dickinson & Co., he served as Senior Vice President of the Drug Delivery sector and President of Nippon Becton Dickinson in Tokyo. Mr. Throdahl began his career at Mallinckrodt, Inc. Mr. Throdahl is a graduate of Princeton University and earned an MBA from Harvard Business School.
- David R. Bailey
David R. Bailey，2007年加入本公司，2009年起担任我们执行副总裁。2007-2013年，Bailey先生担任我们董事会成员。加入我们公司之前，Bailey先生担任Smith & Nephew plc。销售代表和分销商。Bailey先生获得了 Purdue University销售和销售管理学士学位。
David R. Bailey joined our company in 2007 and has served as our Executive Vice President since 2009. Mr. Bailey also served as a member of our Board of Directors from 2007 to 2013. Prior to joining our company, Mr. Bailey worked as a sales representative and distributor for Smith & Nephew plc. Mr. Bailey earned a Bachelor of Science in Sales and Sales Management from Purdue University.- David R. Bailey，2007年加入本公司，2009年起担任我们执行副总裁。2007-2013年，Bailey先生担任我们董事会成员。加入我们公司之前，Bailey先生担任Smith & Nephew plc。销售代表和分销商。Bailey先生获得了 Purdue University销售和销售管理学士学位。
- David R. Bailey joined our company in 2007 and has served as our Executive Vice President since 2009. Mr. Bailey also served as a member of our Board of Directors from 2007 to 2013. Prior to joining our company, Mr. Bailey worked as a sales representative and distributor for Smith & Nephew plc. Mr. Bailey earned a Bachelor of Science in Sales and Sales Management from Purdue University.
- Gregory A. Odle
Gregory A. Odle，他于2007年加入我们公司，也曾一直担任我们执行副总裁（2011年以来）。从2007年到2013年，他也曾担任我们的董事会成员。加入我们公司之前，他曾担任Smith & Nephew plc的多种销售职务，最后成为印第安纳州和肯塔基州的区域经理。他持有the Indiana University Kelley School of Business的市场营销学士学位。
Gregory A. Odle joined our company in 2007 and has served as our Executive Vice President since 2011. Mr. Odle also served as a member of our Board of Directors from 2007 to 2013. Prior to joining our company, Mr. Odle held various sales roles for Smith & Nephew plc, ultimately becoming the District Manager for Indiana and Kentucky. Mr. Odle earned a Bachelor of Science in Marketing from the Indiana University Kelley School of Business.- Gregory A. Odle，他于2007年加入我们公司，也曾一直担任我们执行副总裁（2011年以来）。从2007年到2013年，他也曾担任我们的董事会成员。加入我们公司之前，他曾担任Smith & Nephew plc的多种销售职务，最后成为印第安纳州和肯塔基州的区域经理。他持有the Indiana University Kelley School of Business的市场营销学士学位。
- Gregory A. Odle joined our company in 2007 and has served as our Executive Vice President since 2011. Mr. Odle also served as a member of our Board of Directors from 2007 to 2013. Prior to joining our company, Mr. Odle held various sales roles for Smith & Nephew plc, ultimately becoming the District Manager for Indiana and Kentucky. Mr. Odle earned a Bachelor of Science in Marketing from the Indiana University Kelley School of Business.
- Daniel J. Gerritzen
Daniel J. Gerritzen先生自2009年1月起担任法律和人力资源的总法律顾问和副总裁。在加入我们公司之前，Gerritzen先生是Bingham Greenbaum Doll LLP（一家印第安纳波利斯律师事务所）的合伙人， 担任律师。 Gerritzen先生大部分时间都在为我们公司工作。 Gerritzen先生获得了 Indiana University市场营销的学士学位和法学博士学位。
Daniel J. Gerritzen has served as our General Counsel and Secretary and as our Vice President of Legal and Human Resources since January 2009. Prior to joining our company, Mr. Gerritzen was a partner with Bingham Greenebaum Doll LLP now known as Dentons Bingham Greenebaum LLP, a law firm in Indianapolis, where he continues to serve as Of Counsel. Mr. Gerritzen spends substantially all of his time working for our company. Mr. Gerritzen earned a Bachelor of Science in Marketing and a JD from Indiana University.- Daniel J. Gerritzen先生自2009年1月起担任法律和人力资源的总法律顾问和副总裁。在加入我们公司之前，Gerritzen先生是Bingham Greenbaum Doll LLP（一家印第安纳波利斯律师事务所）的合伙人， 担任律师。 Gerritzen先生大部分时间都在为我们公司工作。 Gerritzen先生获得了 Indiana University市场营销的学士学位和法学博士学位。
- Daniel J. Gerritzen has served as our General Counsel and Secretary and as our Vice President of Legal and Human Resources since January 2009. Prior to joining our company, Mr. Gerritzen was a partner with Bingham Greenebaum Doll LLP now known as Dentons Bingham Greenebaum LLP, a law firm in Indianapolis, where he continues to serve as Of Counsel. Mr. Gerritzen spends substantially all of his time working for our company. Mr. Gerritzen earned a Bachelor of Science in Marketing and a JD from Indiana University.
- Fred L. Hite
Fred L. Hite，2004年3月以来，他一直担任高级副总裁兼首席财务官。他曾担任General Electric Industrial Systems公司的多种职务，包括负责一般电动马达和控制的财务经理（从2001年到2004年）、制造业财务经理（从2000年到2001年）、工程服务财务经理（从1997年到2000年）。从1995年到1997年，他曾担任General Electric Industrial Control Systems的采购财务经理和商业金融分析师。从1990年到1995年，他曾担任General Electric Appliances公司的多种财务职务。他持有印第安纳大学（Indiana University-Bloomington）的财务学士学位。
Fred L. Hite has served as our Chief Financial Officer since February 2015 and as a director since August 2015. Prior to joining our company, from 2004 through 2014 Mr. Hite served as the Chief Financial Officer and Investor Relations Officer of Symmetry Medical Inc., or Symmetry, a company previously listed on the New York Stock Exchange. Prior to joining Symmetry, Mr. Hite spent 13 years with General Electric Corporation in a variety of financial positions and areas including commercial, manufacturing, sourcing and services. Mr. Hite earned a Bachelor of Science in Finance from the Indiana University Kelley School of Business.- Fred L. Hite，2004年3月以来，他一直担任高级副总裁兼首席财务官。他曾担任General Electric Industrial Systems公司的多种职务，包括负责一般电动马达和控制的财务经理（从2001年到2004年）、制造业财务经理（从2000年到2001年）、工程服务财务经理（从1997年到2000年）。从1995年到1997年，他曾担任General Electric Industrial Control Systems的采购财务经理和商业金融分析师。从1990年到1995年，他曾担任General Electric Appliances公司的多种财务职务。他持有印第安纳大学（Indiana University-Bloomington）的财务学士学位。
- Fred L. Hite has served as our Chief Financial Officer since February 2015 and as a director since August 2015. Prior to joining our company, from 2004 through 2014 Mr. Hite served as the Chief Financial Officer and Investor Relations Officer of Symmetry Medical Inc., or Symmetry, a company previously listed on the New York Stock Exchange. Prior to joining Symmetry, Mr. Hite spent 13 years with General Electric Corporation in a variety of financial positions and areas including commercial, manufacturing, sourcing and services. Mr. Hite earned a Bachelor of Science in Finance from the Indiana University Kelley School of Business.